New lung cancer drug shows dramatic results for shrinking tumors Phase III clinical trial being offered Digg this page for free send this page to a friend Add to your del.icio.us account

Patients with a specific kind of lung cancer may benefit from a Phase III clinical trial being offered. The new drug, crizotinib, under development by Pfizer, showed dramatic results in reducing lung cancer tumors in some patients during Phase I and II clinical trials.
User comments, Ratings and Reviews
News Reviews and Ratings
Be the first person to review this news article. By reviewing the news article you are automatically sent to our Online Sweepstakes and any questions on journal postings and more info from here
News Album Team,  Wednesday, June 19, 2013 10:58:33 PM
Note: To write new journal then start here. The below is only to re-write the existing journal
Write your own Review on This News:

Required valid email. Confirmation sent here.
Not Much. 1 2 3 4 5 So Much......!

Human Verification Code     
Read more! [Bookmark & read later / Comment this story ] / realated stories]
Share this article:

You can Digg this article: Digg this page for free
Send Page to Friend(s):send this page to a friend
Bookmark with del.icio.us:Add to your del.icio.us account

Cast My Opinion

  

Article Taged as : lung, cancer, drug, shows, dramatic, results, shrinking, tumors, phase, clinical, trial, being, offered, http, feeds.sciencedaily.com, sciencedaily, zqosnz1fxni, 100622142603.htm, http, www.sciencedaily.com, newsfeed.xml, sciencedaily, magazine, lung, cancer, drug, shows, dramatic, results, shrinking, tumors, phase, clinical, trial, being, offered,

Article Statistics

Article Viewed 930 times.
Positive attitude 1 votes [0%]
Negetive attitude 1 votes [0%]

News Article Source & Groups


sciencedaily magazine
your link to the latest research news. daily headlines about discoveries in the physical and life sciences, health and medicine, the environment, and technology, from the world's leading universities and research centers. The Submitted XML Type text/xml; charset=UTF-8 and gathered so far 334956 bytes of news and keep on growing. Submit Server name is GSE and Code Page 65001 (Not Defined/Un Known)

: : New lung cancer drug shows dramatic results for shrinking tumors Phase III clinical trial being offered
Date Listed : Tuesday, June 22, 2010
Source : ,

Related Stories
Home | Topics | Tell a Friend | Webmaster | Events | Subscribe | Link us | Submit News | My List